Pancreatic Cancer Research

ResearcherUniversity of LiverpoolActive in the last 2 years

Pedro Antonio Pérez-Mancera

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4483-5136; OpenAlex author ID A5050182718. Sources: OpenAlex.

Their work

Papers
15 (first author 3, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
62
Papers, trials and grants by year

2012: 2 papers · 2013: none · 2014: 1 paper · 2015: none · 2016: 1 paper · 2017: 1 paper · 2018: none · 2019: 2 papers · 2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper · 2024: 2 papers · 2025: 1 paper · 2026: 3 papers

Papers 15

  1. Evaluating the impact of dynamic fluid flow on an advanced model of pancreatic cancer: Towards desmoplasia disruption and chemosensitivity promotion. Co-author DOI 10.1016/j.bioadv.2026.214984↗
  2. Correction to "Mapping Tumor-Stroma-ECM Interactions in Spatially Advanced 3D Models of Pancreatic Cancer". Co-author DOI 10.1021/acsami.6c14723↗
  3. NQO1 as a predictor of response to adjuvant GemCap treatment for pancreatic cancer. Co-author DOI 10.1093/jnci/djaf345↗
  4. Mapping Tumor-Stroma-ECM Interactions in Spatially Advanced 3D Models of Pancreatic Cancer. Co-author DOI 10.1021/acsami.5c02296↗
  5. Chemotherapy Assessment in Advanced Multicellular 3D Models of Pancreatic Cancer: Unravelling the Importance of Spatiotemporal Mimicry of the Tumor Microenviro… Co-author DOI 10.1002/adbi.202300580↗
  6. Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis. Last author DOI 10.1158/0008-5472.can-23-3419↗
  7. The role of microRNAs in the modulation of cancer-associated fibroblasts activity during pancreatic cancer pathogenesis. Last author DOI 10.1007/s13105-022-00899-0↗
  8. A Novel Scaffold-Based Hybrid Multicellular Model for Pancreatic Ductal Adenocarcinoma-Toward a Better Mimicry of the in vivo Tumor Microenvironment. First author DOI 10.3389/fbioe.2020.00290↗
  9. Chemoradiotherapy screening in a novel biomimetic polymer based pancreatic cancer model. Co-author DOI 10.1039/c9ra09123h↗
  10. Oncogenic KRAS Induces NIX-Mediated Mitophagy to Promote Pancreatic Cancer. Co-author DOI 10.1158/2159-8290.cd-18-1409↗
  11. Designing a bio-inspired biomimetic in vitro system for the optimization of ex vivo studies of pancreatic cancer. Co-author DOI 10.1016/j.drudis.2017.01.012↗
  12. Chemoresistance in Pancreatic Cancer Is Driven by Stroma-Derived Insulin-Like Growth Factors. Co-author DOI 10.1158/0008-5472.can-16-1201↗
  13. STAG2 is a clinically relevant tumor suppressor in pancreatic ductal adenocarcinoma. First author DOI 10.1186/gm526↗
  14. The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma. First author DOI 10.1038/nature11114↗
  15. What we have learned about pancreatic cancer from mouse models. Co-author DOI 10.1053/j.gastro.2012.03.002↗

Closest collaborators

The 25 strongest of 62 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Eirini G. Velliou · 7 shared papers, 2017–2026 · strength 1.47
  2. Priyanka Gupta · 6 shared papers, 2019–2026 · strength 1.40
  3. Hemant Mahendrakumar Kocher · 5 shared papers, 2020–2026 · strength 1.30
  4. Camino Bermejo‐Rodríguez · 3 shared papers, 2023–2024 · strength 0.68
  5. Lawrence N. Barrera · 3 shared papers, 2023–2026 · strength 0.61
  6. Anna-Dimitra Kataki · 2 shared papers, 2025–2026 · strength 0.58
  7. Yaohe Wang · 2 shared papers, 2025–2026 · strength 0.58
  8. Eithne Costello · 3 shared papers, 2017–2026 · strength 0.52
  9. David Arthur Tuveson · 5 shared papers, 2012–2024 · strength 0.35
  10. John P. Neoptolemos · 2 shared papers, 2017–2026 · strength 0.28
  11. William Greenhalf · 2 shared papers, 2017–2026 · strength 0.28
  12. Youngkyu Park · 2 shared papers, 2019–2024 · strength 0.24
  13. Giuseppe Schettino · 2 shared papers, 2019–2020 · strength 0.24
  14. Lucy S. Oldfield · 1 shared paper, 2026 · strength 0.22
  15. Paula Ghaneh · 1 shared paper, 2026 · strength 0.22
  16. Markus Wolfgang Büchler · 1 shared paper, 2026 · strength 0.22
  17. Thilo Hackert · 1 shared paper, 2026 · strength 0.22
  18. Christoph Springfeld · 1 shared paper, 2026 · strength 0.22
  19. Kate Murray · 1 shared paper, 2026 · strength 0.22
  20. Dylan Williams · 1 shared paper, 2026 · strength 0.22
  21. Christoph W. Michalski · 1 shared paper, 2026 · strength 0.22
  22. Christopher Michael Halloran · 1 shared paper, 2026 · strength 0.22
  23. Daniel H. Palmer · 1 shared paper, 2026 · strength 0.22
  24. Thomas Knösel · 3 shared papers, 2012–2024 · strength 0.21
  25. Christian P. Pilarsky · 3 shared papers, 2012–2024 · strength 0.21

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.